Thierry Walzer

InstitutionCNRS
AddressLyon
France
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 3 publications in August 2021
    All Publications
    Bar chart showing 101 publications over 19 distinct years, with a maximum of 14 publications in 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Mouton W, Compagnon C, Saker K, Daniel S, Djebali S, Lacoux X, Pozzetto B, Oriol G, Laubreton D, Prieux M, Fassier JB, Guibert N, Massardier-Pilonchéry A, Alfaiate D, Berthier F, Walzer T, Marvel J, Brengel-Pesce K, Trouiller-Assant S. Specific detection of memory T-cells in COVID-19 patients using standardized whole-blood Interferon gammarelease assay. Eur J Immunol. 2021 12; 51(12):3239-3242. PMID: 34387859.
      Citations: 1     Fields:    Translation:HumansCells
    2. Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10). PMID: 34415984.
      Citations: 1     Fields:    
    3. Goncalves D, Mezidi M, Bastard P, Perret M, Saker K, Fabien N, Pescarmona R, Lombard C, Walzer T, Casanova JL, Belot A, Richard JC, Trouillet-Assant S. Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients. Clin Transl Immunology. 2021; 10(8):e1327. PMID: 34429968.
      Citations: 8     
    4. Lopez J, Mommert M, Mouton W, Pizzorno A, Brengel-Pesce K, Mezidi M, Villard M, Lina B, Richard JC, Fassier JB, Cheynet V, Padey B, Duliere V, Julien T, Paul S, Bastard P, Belot A, Bal A, Casanova JL, Rosa-Calatrava M, Morfin F, Walzer T, Trouillet-Assant S. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10). PMID: 34357402.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    5. Citations: 7     Fields:    Translation:HumansCells
    6. Legros V, Denolly S, Vogrig M, Boson B, Siret E, Rigaill J, Pillet S, Grattard F, Gonzalo S, Verhoeven P, Allatif O, Berthelot P, Pélissier C, Thiery G, Botelho-Nevers E, Millet G, Morel J, Paul S, Walzer T, Cosset FL, Bourlet T, Pozzetto B. A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity. Cell Mol Immunol. 2021 02; 18(2):318-327. PMID: 33408342.
      Citations: 69     Fields:    Translation:Humans
    7. Fauter M, Viel S, Zaepfel S, Pradat P, Fiscus J, Villard M, Garnier L, Walzer T, Sève P, Henry T, Jamilloux Y. Low glycosylated ferritin is a sensitive biomarker of severe COVID-19. Cell Mol Immunol. 2020 11; 17(11):1183-1185. PMID: 32917980.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    8. Jamilloux Y, Henry T, Belot A, Viel S, Fauter M, El Jammal T, Walzer T, François B, Sève P. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020 Jul; 19(7):102567. PMID: 32376392.
      Citations: 229     Fields:    Translation:HumansCellsPHPublic Health